Re: Thoughts on ZCC
in response to
by
posted on
Sep 06, 2021 07:44PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Tada, I would also hope there would be some sort of premium for the royalty preferreds and what we're told is a great depth of IP. The main reasons I would like to see a lock stock and barrel sale of ZCC would be 1)no room for current management to make decisions on how the funds from a sale are distributed, not true if just ZEL is sold and 2)if some BP buys the whole package including the royalty preferreds they would likely be motivated to become involved in making RVX a success.